CoChat

Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis

Open access
Dubois-Camacho, Karen, Diaz-Jimenez, David, De la Fuente, Marjorie, Quera, Rodrigo, Simian, Daniela, Martínez, Maripaz, Landskron, Glauben, Olivares-Morales, Mauricio, Cidlowski, John A., Xu, Xiaojiang, Gao, Guangping, Xie, Jun, Chnaiderman, Jonás, Soto-Rifo, Ricardo, González, María-Julieta, Calixto, Andrea, Hermoso, Marcela A. · 2019 · Frontiers in Immunology
Cited by 48

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa damage associated to an uncontrolled inflammatory response. This immunological impairment leads to altered inflammatory mediators such as IL-33, which is shown to increase in the mucosa of active UC (aUC) patients. MicroRNAs present a distorted feature in inflamed colonic mucosa and are potential IL-33 regulating candidates in UC. Therefore, we studied the microRNA and mRNA profiles in inflamed colonic samples of UC patients, evaluating the effect of a microRNA (selected by in silico analysis and its expression in UC patients), on IL-33 under inflammatory conditions. We found that inflamed mucosa (n=8) showed increased expression of 40 microRNAs and 2120 mRNAs, while 49 microRNAs and 1734 mRNAs were decreased, as determined by microarrays. In particular, IL-33 mRNA showed a 3.8-fold increase and 8 members of a microRNA family (miR-378), which targets IL-33 mRNA in the 3’UTR, were decreased (-3.9 to -3.0 times). We selected three members of the miR-378 family (miR-378a-3p, miR-422a, miR-378c) according to background information and interaction energy analysis, for further correlation analyses with IL-33 expression through RT-qPCR and ELISA respectively. We determined that aUC (n=24) showed high IL-33 levels, and decreased expression of miR-378a-3p and miR-422a compared to inactive UC (n=10) and controls (n=6). While miR-378c do not show a significant difference, miR-378a-3p and miR-422a were inversely correlated with IL-33 expression. To evaluate the possible effect of TNF-alfa on the studied microRNAs, aUC patients with anti-TNF therapy were compared to aUC receiving other treatments. The levels of miR-378a-3p and miR-378c were higher in aUC patients with anti-TNF. In base to these findings we selected miR-378a-3p to exploring the molecular mechanism involved by in vitro assays, showing that over-expression of miR-378a-3p decreased the levels of an IL-33 target sequence β-gal-reporter gene in HEK293 cells. Stable miR-378a-3p over-expression/inhibition inversely modulated IL-33 content and altered viability of HT-29 cells. Additionally, in an inflammatory context, TNF-alfa decreased miR-378a-3p levels in HT-29 cells enhancing IL-33 expression. Together, our results propose a regulatory mechanism of IL-33 expression exerted by miR-378a-3p in an inflammatory environment, contributing to the understanding of UC pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2019.02449

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 48

Metadata

Authors
Dubois-Camacho, K., Diaz-Jimenez, D., De la Fuente, M., Quera, R., Simian, D., Martínez, M., Landskron, G., Olivares-Morales, M., Cidlowski, J. A., Xu, X., Gao, G., Xie, J., Chnaiderman, J., Soto-Rifo, R., González, M.-J., Calixto, A., & Hermoso, M. A.
Venue
Frontiers in Immunology
Published
2019-11-20
Volume
10
Pages
2449-2449
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2981216329
Cited by
48
References
5
FWCI
3.93
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.